Literature DB >> 7694761

Evidence that M1 muscarinic receptors enhance noradrenaline release in mouse atria by activating protein kinase C.

M Costa1, M Barrington, H Majewski.   

Abstract

1. The M1 selective muscarinic agonist, McNeil A 343, enhanced the electrically evoked release of noradrenaline from postganglionic sympathetic nerves in mouse atria. This has been found previously to be due to activation of muscarinic receptors of the M1 subtype, probably located on sympathetic nerve terminals. The present study investigated the signal transduction mechanisms involved in the release-enhancing effects of McNeil A 343. The release of noradrenaline from mouse atria was assessed by measuring the electrically-induced (3 Hz, 60 s) outflow of radioactivity from atria which had been pre-incubated with [3H]-noradrenaline. 2. 8-Bromo cyclic AMP in the presence of IBMX was used to enhance maximally S-I noradrenaline release through cyclic AMP-dependent mechanisms. However, the facilitatory effect of McNeil A 343 (10 microM) was not different from the effect in the absence of these drugs, suggesting that McNeil A 343 enhances noradrenaline release independently of the cyclic AMP system. Furthermore, the release-enhancing effect of McNeil A 343 (10 microM) on noradrenaline release was also not altered by the 5-lipoxygenase inhibitor, BW A4C. 3. The facilitatory effect of McNeil A 343 was not altered in the presence of drugs (trifluoperazine, W7, and calmidazolium) which inhibit calmodulin-dependent processes, suggesting that the mechanisms of action of McNeil A 343 does not depend on calmodulin. 4. It was considered likely that the facilitatory effect of McNeil A 343 on noradrenaline release may be due to activation of protein kinase C, since activators of protein kinase C enhance noradrenaline release. The facilitatory effect of McNeil A 343 was abolished by the non-selective protein kinase C inhibitor,K-252a. To investigate further the involvement of protein kinase C, mouse atria were chronically incubated (9-O h) with the protein kinase C activator, 4 beta-phorbol dibutyrate (1.0 microM) in order to down-regulate protein kinase C activity. In protein kinase C-down-regulated atria, the facilitatory effect of McNeil A 343 (30 microM) was abolished. Incubation with 4 alpha-phorbol dibutyrate which does not affect protein kinase C did not reduce the facilitatory effect of McNeil A 343. This provides evidence that activation of protein kinase C is involved in the signal transduction process of McNeil A 343.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7694761      PMCID: PMC2175939          DOI: 10.1111/j.1476-5381.1993.tb13899.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  44 in total

Review 1.  Basic mechanisms of prostaglandin action on autonomic neurotransmission.

Authors:  P Hedqvist
Journal:  Annu Rev Pharmacol Toxicol       Date:  1977       Impact factor: 13.820

2.  Muscarinic cholinergic receptors in rat corpus striatum and regulation of guanosine cyclic 3',5'-monophosphate.

Authors:  M R Hanley; L L Iversen
Journal:  Mol Pharmacol       Date:  1978-03       Impact factor: 4.436

3.  Selective binding of antipsychotics and other psychoactive agents to the calcium-dependent activator of cyclic nucleotide phosphodiesterase.

Authors:  R M Levin; B Weiss
Journal:  J Pharmacol Exp Ther       Date:  1979-03       Impact factor: 4.030

Review 4.  Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases.

Authors:  U T Rüegg; G M Burgess
Journal:  Trends Pharmacol Sci       Date:  1989-06       Impact factor: 14.819

5.  Modulation by the muscarinic agonist McN-A-343 of noradrenaline release from vascular sympathetic neurones.

Authors:  O A Nedergaard
Journal:  J Cardiovasc Pharmacol       Date:  1980 Sep-Oct       Impact factor: 3.105

6.  Peripheral muscarinic control of norepinephrine release in the cardiovascular system.

Authors:  E Muscholl
Journal:  Am J Physiol       Date:  1980-12

7.  Regional sensitivity of cyclic AMP and cyclic GMP in rat brain to central cholinergic stimulation.

Authors:  R H Lenox; G J Kant; J L Meyerhoff
Journal:  Life Sci       Date:  1980-06-23       Impact factor: 5.037

8.  Release of prostaglandin from the rabbit isolated heart following vagal nerve stimulation or acetylcholine infusion.

Authors:  M Junstad; A Wennmalm
Journal:  Br J Pharmacol       Date:  1974-11       Impact factor: 8.739

9.  Atropine-resistant effects of the muscarinic agonists McN-A-343 and AHR 602 on cardiac performance and the release of noradrenaline from sympathetic nerves of the perfused rabbit heart.

Authors:  J R Fozard; E Muscholl
Journal:  Br J Pharmacol       Date:  1974-04       Impact factor: 8.739

10.  Effects of McN-A-343 and DMPP on the uptake and release of 3 H-noradrenaline by guinea-pig atria.

Authors:  G S Allen; M J Rand; D F Story
Journal:  Br J Pharmacol       Date:  1972-07       Impact factor: 8.739

View more
  3 in total

Review 1.  The regulation of neurotransmitter secretion by protein kinase C.

Authors:  P F Vaughan; J H Walker; C Peers
Journal:  Mol Neurobiol       Date:  1998-10       Impact factor: 5.590

2.  M1 muscarinic receptor-induced facilitation of ACh and noradrenaline release in the rat bladder is mediated by protein kinase C.

Authors:  G T Somogyi; M Tanowitz; G Zernova; W C de Groat
Journal:  J Physiol       Date:  1996-10-01       Impact factor: 5.182

3.  Facilitation of transmitter release from rat sympathetic neurons via presynaptic P2Y(1) receptors.

Authors:  Giri K Chandaka; Isabella Salzer; Helmut Drobny; Stefan Boehm; Klaus W Schicker
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.